AstraZeneca Surges Ahead: Q2 Revenue Jumps 12% to $14.5 Billion Amid Strategic Growth Plans
AstraZeneca announces a 12% increase in Q2 revenue to $14.5 billion, with product sales up by 11%. The company also reports a 27% rise in EPS to $1.58, alongside strategic investme...